Diagnostic and Interventional Cardiology

Zach Williams wanted to be a cancer researcher, but quick success in another area refocused his research on cardiovascular science. He was awarded a National Institutes of Health grant to fund his research for two years. Image courtesy of Clayton Metz/Virginia Tech.

Virginia Tech Graduate Student Earns NIH Support to Explore Promising Heart Finding

October 13, 2022 — Zach Williams thought he’d become a cancer researcher when he joined Virginia Tech’s Translational ...

October 13, 2022

Videos | TCT

VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's ...

October 13, 2022

The Delphi study results show Philips’ integrated echocardiography solution provides the tools required for baseline risk stratification and monitoring of cardio-oncology patients as recommended by the latest European Society of Cardiology (ESC) guidelines

News | Heart Failure

Panel of Experts Highlights Clinical and Operational Benefits of Philips’ Integrated Echocardiography Solution

October 12, 2022 — Following the recent European Society of Cardiology (ESC) Congress in Barcelona, Spain last month ...

October 12, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Study investigates metformin and other candidate drugs through a network medicine approach

News | Heart Failure

Cleveland Clinic Researchers Identify Diabetes Drug Metformin as Potential Atrial Fibrillation Treatment in Collaborative Research

October 12, 2022 — Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible ...

October 12, 2022

Renowned Stanford Cardiologist Brings Deep Clinical, Research, and Industry Expertise to Executive Team

News | Cardiovascular Business

HeartBeam Names Peter J. Fitzgerald, MD, PhD, as Chief Medical Officer

October 12, 2022 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG ...

October 12, 2022

Share Images Automatically, Instantly, and Securely

Sponsored Content | Whitepapers | Archive Cloud Storage

Strategic Planning for Imaging in the Cloud

Change Healthcare’s cloud-native archiving, viewing, and image-sharing solutions can help improve efficiencies in ...

October 11, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

Results now available for the first 10 patients being treated with the ELANA open heart bypass solution as part of a SAFE-CAB trial.

News | Cardiovascular Clinical Studies

ELANA Heart Bypass Solution Shows Promising Preliminary Results in First-in-Human Trials

October 11, 2022 — The preliminary results of the first-in-human (FIH) trials for the innovative ELANA Heart Bypass ...

October 11, 2022

Researchers from the University of Minnesota Medical School found that patients with certain features on magnetic resonance imaging (MRI) of the heart are at much higher risk for cardiac sarcoidosis-related adverse outcomes.

News | Cardiac Imaging

Identifying Patients with Sarcoidosis at Risk for Bad Cardiac Outcomes

October 11, 2022 — Researchers from the University of Minnesota Medical School found that patients with certain features ...

October 11, 2022

Grant Proceeds Will Support Pre-Clinical Studies

News | Stents Bioresorbable

Efemoral Medical Awarded Phase II SBIR Grant from NIH to Advance Treatment for Peripheral Artery Disease

October 11, 2022 — Efemoral Medical, developer of advanced interventional bioresorbable therapies, announced that it has ...

October 11, 2022

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

News | Stroke

Identifying How Inflammation Affects Stroke Recovery

October 7, 2022 — A new research grant will enable University of Cincinnati researchers to learn more about how ...

October 07, 2022

Ultromics, a digital health technology company pioneering the development of transformative heart failure diagnostics, has joined as a full partner The Accelerating Medicines Partnership® Heart Failure (AMP HF) including the National Institutes of Health (NIH) and the National Heart Lung and Blood Institute (NHLBI), managed by the Foundation for the National Institutes of Health (FNIH).

News | Heart Failure

Ultromics joins FNIH Partnership to Transform Heart Failure Detection

October 7, 2022 — Ultromics, a digital health technology company pioneering the development of transformative heart ...

October 07, 2022

This is the first study to investigate the safety and tolerability of NR in a randomized, placebo-controlled trial of patients with heart failure, marking a milestone for future clinical research

News | Heart Failure

ChromaDex Shares Promising Findings from Clinical Study Showcasing the Safety and Tolerability of Nicotinamide Riboside (NR) in Heart Failure With Reduced Ejection Fraction

October 7, 2022 — ChromaDex Corp. announced promising findings from a clinical study, as reported in the peer-reviewed ...

October 07, 2022

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Rutgers study finds post-surgical hospitalization rates from left ventricular assist devices varied by socioeconomic factors

News | Heart Failure

Lower-Income Patients with Heart Pumps More Likely Hospitalized with Major Bleeding, Infection or Heart Failure

October 6, 2022 — The complications experienced by heart failure patients implanted with a left ventricular assist ...

October 06, 2022

Research collaboration involving NYU Tandon School of Engineering, NYU Langone and the Food and Drug Administration will focus on biomarker data to improve performance analysis of stroke rehabilitation equipment. Image credit: Shidlovski

News | Stroke

NYU Researchers Partner with FDA to Identify Biomarkers for Stroke Rehabilitation

October 6, 2022 — Stroke is the leading cause of age-related motor disabilities and is becoming more prevalent in ...

October 06, 2022

OpSens Inc. has announced that it has received 510(k) regulatory clearance from the U.S. Food & Drug Administration (FDA) for the SavvyWire, its new guidewire for transcatheter aortic valve replacement (TAVR) procedures.

News | Cardiovascular Business

OpSens Announces FDA Clearance for the SavvyWire for Use in Transcatheter Aortic Valve Replacement (TAVR) Procedures

October 6, 2022 – OpSens Inc., a Quebec-based medical device cardiology-focused company, has announced that it has ...

October 06, 2022